A method for treating a patient includes providing a delivery device capable of generating a magnetic field, placing the device above or below the skin, and directing the agent into the patient's skin via the device. The therapeutic agent is directed to a treatment site through the skin. Systems for directing agents are also included herein.

There are many devices that are used to deliver electromagnetic energy to biological tissues. However, physical properties of current techniques limit the strength and efficacy of the applied field. This invention introduces a new apparatus for the application of evanescent waves into biological tissue. The apparatus is planar, conformal, and electrically insulated and is comprised of two or more conductive regions spatially separated by a non-conductive gap insulated by low-dielectric constant, non-conductive material. The apparatus is powered by one or more RF/voltage sources that can be applied to individual or several conductive regions to create voltage differentials that generate evanescent waves. The apparatus can be used for treating cancer tumors, deep brain stimulation, and other therapeutic purposes.

A therapeutic method of reducing or eliminating viral infections in vivo includes subjecting a virally infected patient to one of a variety of strong magnetic fields. A static magnetic field has a magnetic field intensity of at least about 5 nanoTesla sufficient to be effective to disrupt viral metabolism. An alternating magnetic field has a magnetic field intensity of at least 0.1 nanoTesla sufficient to be effective to disrupt viral metabolism. A method of disrupting viral metabolism includes subjecting an infected patient or a mixture of live host cells and virus to the alternating magnetic field. A virus disruption apparatus includes a magnetic field generator of static or alternating magnetic fields. The magnetic field generator is selected from a Magnetic Resonance Imaging device, at least one permanent magnet, at least one superconducting magnet, at least one solenoid, and any combination thereof.

A device for enhancement of visual appearance including a first applicator to be coupled to a first area of a body region, with a first magnetic field generating device and a first radiofrequency electrode, a second applicator to be coupled to a second area of the body region, with a second magnetic field generating device. The device further includes a first energy storage device, a second energy storage device, and a first switching device to discharge energy from the first energy storage device to the first magnetic field generating to generate a first time-varying magnetic field to cause muscle contraction, and a second switching to discharge energy from the second energy storage device to the second magnetic field generating device to generate a second time-varying magnetic field. The first radiofrequency electrode may provide first radiofrequency waves causing heating of tissue within the first area of the body region.

The present invention relates to a nanohelix-substrate complex for controlling adhesion and polarization of macrophages, a manufacturing method thereof, and a method of controlling adhesion and polarization of macrophages by using the nanohelix-substrate complex, and the method of controlling adhesion and polarization of macrophages may temporally and reversibly control adhesion and phenotypic polarization of macrophages in vivo and ex vivo by controlling application/non-application of a magnetic field to the nanohelix-substrate complex.

Provided is an acumoxa therapy device utilizing energy waves for preventing, alleviating or treating COVID-19 (SARS-CoV-2) coronavirus infection. In one embodiment, the device delivers energy in a non-invasive manner. In one embodiment, the device is configured to include an energy pin (103) and one or more energy rings (104). In one embodiment, the device delivers sufficient energy to certain body parts such as acupoints to achieve an intervening and/or therapeutic effect. In one embodiment, the device can maintain or improve general health, or can alleviate or treat a subject with COVID-19 infection and one or more other conditions. In one embodiment, a system comprising the device and uses thereof is also disclosed.

A system and method for determining and modifying the electromagnetic activity of a patient's heart includes a sensor array, a controller, software, and a stimulator array. The sensor array includes one or more sensors, such as an ECG electrode, that detect the electromagnetic activity of a patient's heart. The sensor array is in data communication with the controller. The controller runs software that outputs in human-format sensor data provided by the sensor array. The software receives data from the controller, analyzes the data, presents the data to the user, and sends the data to the stimulator array via a data communication link. The stimulator array includes one or more electromagnets and at least one or more light-emitting diodes. The stimulator array emits an electromagnetic (and/or light) field to modify the electromagnetic activity of a patient's heart based on the data it receives from the controller. The system can be portable.

This disclosure relates to a therapeutic crate system for housing an animal, the crate system comprising a crate housing including a top wall, a bottom wall located opposite the top wall, and side walls extending between the top wall and the bottom wall. In some embodiments, the therapeutic crate system comprises a sensor coupled to the crate housing, the sensor configured to determine a distance between the animal and the sensor. According to some embodiments, the therapeutic crate system comprises an energized panel coupled to a wall selected from the group consisting of the top wall, the bottom wall, and at least one of the side walls, and operatively coupled to the sensor, the energized panel configured to deliver a type of therapy selected from the group consisting of phototherapy, PEMF treatments, and sound therapy.

A device for treatments on the human body with variable magnetic fields, which is provided with: at least one electric waveform generator to be connected to at least one Helmholtz coil to be brought close to the person or persons to be treated and producing variable low-intensity and low-frequency magnetic fields. The device further includes at least one impedance meters with electrode terminals to be applied to the person in order to assess the effectiveness of the waves of the generator; and at least one electronic processing unit for the management of the waveform generator or generators as a function of the measurements of the impedance meter and of memory parameters stored in the processing unit.

The invention relates to an electromedical implantable or extracorporeally applicable device for treating and monitoring organs as well as a method for therapeutic organ treatment. The aim of the invention is to create an electromedical implantable or externally applicable device which allows healing processes to be excited in diseased organs. Said aim is achieved by an electromedical implantable or extracorporeally applicable device for treating and monitoring organs, comprising a programmable generator and receiver unit which generates and receives electrical microcurrents and electromagnetic power and is connected in a conducting manner to electrodes, a telemetry unit that is integrated into the generator and receiver unit and is provided with a transmitter and a receiver for exchanging data with extracorporeal devices, and a power supply unit.